TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06458712: Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Sponsor: Duke Street Bio Ltd · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 180 pts

Competing Trials Overlap

13 Active Trials

Excess Burn Exposure

$2,230,536

Rescue Site Savings

+$1,476,552

Unlock Full NCT06458712 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06458712 Rescue Dossier →